The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles.

Area of Science:

• Immunology
• Toxicology
• Molecular Biology

Background:

• Diuron (DCMU) is a common herbicide with known adverse effects on human immune cells.
• Immune cells, particularly CD8+ T cells, are crucial for combating infections and preventing cancer development.

Purpose of the Study:

• To investigate the impact of diuron on the human immune response against cancer, focusing on CD8+ T cell activity.
• To elucidate the molecular mechanisms, including miRNA modulation, underlying diuron's effects on anti-cancer immunity.

Main Methods:

• Combined functional assays with miRNA and RNA sequencing.
• Dose-dependent evaluation of diuron's effects on gene and miRNA expression.
• Utilized miRNA mimics and anti-miRs to identify key regulatory miRNAs.
• Validated findings using in vitro cell cultures and an in vivo zebrafish model.

Main Results:

• Diuron exposure modulated miRNA expression in a dose-dependent manner.
• Observed significant changes in gene expression patterns, leading to reduced cytokine and granzyme B secretion.
• Identified hsa-miR-3135b and hsa-miR-21-5p as key regulators of these secretions.
• Demonstrated decreased CD8+ T cell cytotoxic activity against cancer cells both in vitro and in vivo.

Conclusions:

• Diuron diminishes the cytotoxic capacity of CD8+ T cells by altering miRNA expression and function.
• These effects create an immunosuppressive environment that may facilitate cancer development.
• The study highlights the potential risks of diuron exposure to anti-cancer immunity.